Aspira Pathlab Board Approves Q2 FY27 Un-Audited Financial Results

Aspira Pathlab & Diagnostics Ltd announced that its Board of Directors, in a meeting held on November 6, 2026, approved the Un-Audited Standalone Financial Results for the Second Quarter and half-yearly ended September 30, 2026. The Board also took on record the Auditor's Limited Review Report on these results. The meeting commenced at 1:30 PM IST and concluded at 4:00 PM IST. The financial results and review report have been submitted in compliance with SEBI (LODR) Regulations, 2015.